Characterisation of glycan ligands recognised by collectin-11 in ischaemic kidney and development of a specific antagonistic probe

缺血肾中collectin-11识别的聚糖配体的表征以及特异性拮抗探针的开发

基本信息

  • 批准号:
    MR/R010757/1
  • 负责人:
  • 金额:
    $ 93.99万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2018
  • 资助国家:
    英国
  • 起止时间:
    2018 至 无数据
  • 项目状态:
    已结题

项目摘要

The cells making up our tissues and organs are covered with sugar molecules. This coating normally is important in organ development and maintenance but can be a target for our immune system, causing tissue damage. We have found that blood flow disturbance to the kidney can lead to an abnormal pattern of sugars on the cell surface and this triggers inflammation through a molecule called collectin-11. Collectin-11 is a normal tissue product that acts in self defence. However, in abnormal circumstances such as when the organ is donated for transplantation, the sugar pattern can change and this can provoke inflammation and loss of function of the organ. Our aim is to identify the biochemical composition of the abnormal sugar pattern, because this will provide the key to improved treatment and diagnosis. Very simply, if we can work out how collectin-11 recognises the abnormal pattern, we can potentially mask it from collectin-11. The first steps of our research involve extracting a representative sample of the hundreds and possibly thousands of sugars (glycans) found in human kidneys after the organs have been removed from the donor. We can then screen the array of glycans to determine which ones bind strongly to collectin-11. To help us manage the complexity and scale of this procedure, we will make use of robotics to display the glycans and mix them with collectin-11. We can then examine the composition of the most interesting sugars which have strong affinity for collectin-11 and find out where and when they are expressed in kidney biopsies from patients. These studies of human tissue will not only reassure us we are on the right track, but they will help identify which patients could potentially benefit from the treatment to block the abnormal sugar pattern and prevent inflammation. A blocking agent that we are developing for this purpose will need further modification to ensure it fits like a glove over the abnormal sugar. That way the treatment will be more selective and have fewer side effects.
构成我们组织和器官的细胞被糖分子所覆盖。这种涂层通常在器官发育和维护中很重要,但可能是我们免疫系统的目标,导致组织损伤。我们发现,肾脏的血流紊乱会导致细胞表面糖的异常模式,这会通过一种名为collectin-11的分子引发炎症。Collectin-11是一种正常的组织产物,具有自卫作用。然而,在异常情况下,例如器官捐赠用于移植时,糖模式可能会发生变化,这可能会引起炎症和器官功能丧失。我们的目标是确定异常糖模式的生化组成,因为这将提供改善治疗和诊断的关键。很简单,如果我们能弄清楚collectin-11是如何识别异常模式的,我们就有可能从collectin-11中掩盖它。我们研究的第一步涉及在器官从捐赠者身上取出后,提取人体肾脏中发现的数百甚至数千种糖(聚糖)的代表性样本。然后,我们可以筛选聚糖的阵列,以确定哪些聚糖与聚集蛋白11强烈结合。为了帮助我们管理这个过程的复杂性和规模,我们将利用机器人技术来展示聚糖并将其与collectin-11混合。然后,我们可以检查最感兴趣的糖的组成,这些糖对collectin-11具有很强的亲和力,并找出它们在患者肾脏活检中表达的位置和时间。这些对人体组织的研究不仅可以让我们放心,我们走在正确的道路上,而且还可以帮助确定哪些患者可能从阻断异常糖模式和预防炎症的治疗中受益。我们正在为此目的开发的阻断剂需要进一步修改,以确保它像手套一样适合异常糖。这样的治疗将更具选择性,副作用更少。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Collectin-11 (CL-11) Is a Major Sentinel at Epithelial Surfaces and Key Pattern Recognition Molecule in Complement-Mediated Ischaemic Injury.
  • DOI:
    10.3389/fimmu.2018.02023
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
    Nauser CL;Howard MC;Fanelli G;Farrar CA;Sacks S
  • 通讯作者:
    Sacks S
Structural and functional diversity of collectins and ficolins and their relationship to disease.
  • DOI:
    10.1007/s00281-017-0642-0
  • 发表时间:
    2018-01
  • 期刊:
  • 影响因子:
    9
  • 作者:
    Howard M;Farrar CA;Sacks SH
  • 通讯作者:
    Sacks SH
Fucose as a new therapeutic target in renal transplantation.
Local complement synthesis-A process with near and far consequences for ischemia reperfusion injury and transplantation.
局部补体合成-对缺血再灌注损伤和移植具有近远影响的过程。
  • DOI:
    10.1111/imr.13144
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    8.7
  • 作者:
    Nauser CL
  • 通讯作者:
    Nauser CL
Collectin-11 Promotes the Development of Renal Tubulointerstitial Fibrosis.
  • DOI:
    10.1681/asn.2017050544
  • 发表时间:
    2017-11
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Weiju Wu;Chengfei Liu;C. Farrar;Liang Ma;Xia Dong;S. Sacks;Ke Li;Wuding Zhou
  • 通讯作者:
    Weiju Wu;Chengfei Liu;C. Farrar;Liang Ma;Xia Dong;S. Sacks;Ke Li;Wuding Zhou
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Steven Sacks其他文献

Lets connect: A novel role for CD46 in tight junction regulation
  • DOI:
    10.1016/j.molimm.2010.05.166
  • 发表时间:
    2010-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Samia Al-Shouli;John Cardone;Steven Sacks;Claudia Kemper
  • 通讯作者:
    Claudia Kemper
Response of caudal neurosecretory cells of Salvelinus fontinalis to variations in the ionic composition of the environment
  • DOI:
    10.1007/bf00215148
  • 发表时间:
    1984-09-01
  • 期刊:
  • 影响因子:
    2.900
  • 作者:
    Steven Sacks;Gaston Chevalier
  • 通讯作者:
    Gaston Chevalier

Steven Sacks的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Steven Sacks', 18)}}的其他基金

Efficacy of Mirococept (APT070) for Preventing Ischaemia-Reperfusion Injury associated with Kidney Transplantation-2 (EMPIRIKAL-2)
Mirococept (APT070) 预防肾移植相关缺血再灌注损伤的功效-2 (EMPIRIKAL-2)
  • 批准号:
    MR/V038281/1
  • 财政年份:
    2022
  • 资助金额:
    $ 93.99万
  • 项目类别:
    Research Grant
Measuring the impact of monoclonal antibody drugs in cancer and rheumatoid arthritis
测量单克隆抗体药物对癌症和类风湿性关节炎的影响
  • 批准号:
    MC_PC_20057
  • 财政年份:
    2021
  • 资助金额:
    $ 93.99万
  • 项目类别:
    Intramural
Collectin-11 as a trigger of the innate immune response in renal transplantation
Collectin-11 作为肾移植中先天免疫反应的触发因素
  • 批准号:
    MR/M012263/1
  • 财政年份:
    2015
  • 资助金额:
    $ 93.99万
  • 项目类别:
    Research Grant
MRC Centre for Transplantation
MRC 移植中心
  • 批准号:
    MR/J006742/1
  • 财政年份:
    2012
  • 资助金额:
    $ 93.99万
  • 项目类别:
    Research Grant
Development Clinical Studies - investigation into the efficacy of Mirococept in renal transplantation
开发临床研究-Mirococept在肾移植中的疗效调查
  • 批准号:
    G1001197/1
  • 财政年份:
    2011
  • 资助金额:
    $ 93.99万
  • 项目类别:
    Research Grant
Emerging diagnostic and treatment approaches in organ and stem cell transplantation
器官和干细胞移植的新兴诊断和治疗方法
  • 批准号:
    G0600698/1
  • 财政年份:
    2007
  • 资助金额:
    $ 93.99万
  • 项目类别:
    Research Grant
Targeting the complement system in transplantation
移植中针对补体系统
  • 批准号:
    G0600892/1
  • 财政年份:
    2007
  • 资助金额:
    $ 93.99万
  • 项目类别:
    Research Grant

相似国自然基金

系统性探索不同N-glycan修饰对Interferonβ活性和稳定性影响
  • 批准号:
    21877063
  • 批准年份:
    2018
  • 资助金额:
    61.4 万元
  • 项目类别:
    面上项目
胞浆或核定位蛋白质的O-GalNAc糖基化研究
  • 批准号:
    31170771
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
糖药物蛋白Interferonβ N-glycan的均一、人源化改造
  • 批准号:
    81102361
  • 批准年份:
    2011
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目
肠道粘蛋白分子不同O型糖基化调节病原体与肠粘液屏障作用的分子机制研究
  • 批准号:
    81170340
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
发现胰腺癌血清O-连接聚糖生物标记物的新方法
  • 批准号:
    30900254
  • 批准年份:
    2009
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Delivery of anti-bacterial glycan vaccines to cells and subcellular compartments
将抗菌聚糖疫苗递送至细胞和亚细胞区室
  • 批准号:
    10549647
  • 财政年份:
    2023
  • 资助金额:
    $ 93.99万
  • 项目类别:
A Human Salivary Glycome Discovery Platform for Interrogating Glycan Function in Oral Innate Immunity
用于询问口腔先天免疫中聚糖功能的人类唾液糖发现平台
  • 批准号:
    10484608
  • 财政年份:
    2022
  • 资助金额:
    $ 93.99万
  • 项目类别:
Development of a facile, robust, scalable, and versatile chemoenzymatic glycan-remodeling approach for site-specific antibody conjugation
开发一种简便、稳健、可扩展且多功能的化学酶聚糖重塑方法,用于位点特异性抗体缀合
  • 批准号:
    10615237
  • 财政年份:
    2022
  • 资助金额:
    $ 93.99万
  • 项目类别:
Mapping glycan-dependent neurexin interactomes
映射聚糖依赖性神经毒素相互作用组
  • 批准号:
    10675699
  • 财政年份:
    2022
  • 资助金额:
    $ 93.99万
  • 项目类别:
Development of a facile, robust, scalable, and versatile chemoenzymatic glycan-remodeling approach for site-specific antibody conjugation
开发一种简便、稳健、可扩展且多功能的化学酶聚糖重塑方法,用于位点特异性抗体缀合
  • 批准号:
    10484443
  • 财政年份:
    2022
  • 资助金额:
    $ 93.99万
  • 项目类别:
Mapping glycan-dependent neurexin interactomes
映射聚糖依赖性神经毒素相互作用组
  • 批准号:
    10426737
  • 财政年份:
    2022
  • 资助金额:
    $ 93.99万
  • 项目类别:
Discovery and characterization of Siglec glycan ligands via catch-and-release mass spectrometry
通过捕获和释放质谱法发现和表征 Siglec 聚糖配体
  • 批准号:
    565803-2021
  • 财政年份:
    2021
  • 资助金额:
    $ 93.99万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Chemoenzymatic glycan editing for deciphering biological functions of glycans
化学酶聚糖编辑破译聚糖的生物学功能
  • 批准号:
    10555320
  • 财政年份:
    2021
  • 资助金额:
    $ 93.99万
  • 项目类别:
Chemoenzymatic glycan editing for deciphering biological functions of glycans
化学酶聚糖编辑破译聚糖的生物学功能
  • 批准号:
    10799053
  • 财政年份:
    2021
  • 资助金额:
    $ 93.99万
  • 项目类别:
Exploring Siglec-glycan ligand interactions using chemoenzymatic approaches
使用化学酶方法探索 Siglec-聚糖配体相互作用
  • 批准号:
    10297728
  • 财政年份:
    2021
  • 资助金额:
    $ 93.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了